SCHEDULE 13G

BRIACELL THERAPEUTICS CORP

Common Shares, no par value per share (the "Shares") · CUSIP: 107930307

Event date: 2026-01-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Citadel Advisors LLC

  Shares: 716,699.00 · Class: 9.98%

• Citadel Advisors Holdings LP

  Shares: 716,699.00 · Class: 9.98%

• Citadel GP LLC

  Shares: 716,699.00 · Class: 9.98%

• Citadel Securities LLC

  Shares: 499.00 · Class: 0.0%

• Citadel Securities Group LP

  Shares: 499.00 · Class: 0.0%

• Citadel Securities GP LLC

  Shares: 499.00 · Class: 0.0%

• Kenneth Griffin

  Shares: 717,198.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.